By Counterforce Health Team in Bavencio (avelumab) —

How to Get Bavencio (Avelumab) Covered by Blue Cross Blue Shield in Virginia: Complete Appeals Guide 2025

Answer Box: Getting Bavencio Covered in Virginia

Bavencio (avelumab) is covered by Blue Cross Blue Shield in Virginia but requires prior authorization. The fastest path to approval: 1) Your oncologist submits prior authorization with complete clinical documentation to Anthem BCBS Virginia, 2) Include diagnosis confirmation, prior treatment history, and medical necessity justification, 3) If denied, file an internal appeal within plan deadlines, then pursue Virginia's external review through the State Corporation Commission within 120 days. Virginia's external review process provides independent medical review within 45 days (72 hours for urgent cases).

Start today: Contact your oncologist to begin the prior authorization process using Anthem's provider portal and gather all treatment records.

Table of Contents

  1. Coverage Basics: Is Bavencio Covered?
  2. Prior Authorization Process
  3. Timeline Expectations
  4. Clinical Criteria and Requirements
  5. Understanding Costs
  6. Common Denial Reasons and Solutions
  7. Virginia Appeals Process
  8. Specialty Pharmacy Requirements
  9. Frequently Asked Questions
  10. When to Escalate

Coverage Basics: Is Bavencio Covered?

Yes, Bavencio (avelumab) is covered by Blue Cross Blue Shield plans in Virginia as a specialty oncology medication. However, coverage comes with specific requirements:

Coverage at a Glance

Requirement Details Where to Find It
Prior Authorization Required for all uses Anthem Virginia Provider News
Formulary Status Covered as specialty drug Clinical Criteria CC-0129
Step Therapy May apply for urothelial carcinoma Plan-specific PA criteria
Site of Care Restrictions may apply Updated February 2025 guidelines
Quantity Limits Yes, per clinical criteria Anthem specialty pharmacy updates

Which Virginia Plans Cover Bavencio?

  • Anthem Blue Cross Blue Shield Virginia (largest market share ~43%)
  • Other BCBS plans operating in Virginia
  • Coverage criteria are similar across BCBS plans but verify with your specific plan
Note: Self-funded employer plans may have different criteria even if they use BCBS administration.

Prior Authorization Process

Step-by-Step: Fastest Path to Approval

  1. Oncologist Initiates Request (Day 1)
    • Submit via Anthem provider portal or fax
    • Include completed prior authorization form
    • Attach clinical documentation package
  2. Clinical Documentation Required
    • Pathology report confirming diagnosis (Merkel cell carcinoma or urothelial carcinoma)
    • Complete treatment history with dates and outcomes
    • Current staging and imaging results
    • Medical necessity letter from oncologist
  3. Anthem Reviews Submission (5-10 business days)
    • Clinical team evaluates against CC-0129 criteria
    • May request additional information
    • Peer-to-peer review may be offered if initially denied
  4. Decision Notification
    • Approval: Specialty pharmacy coordinates fulfillment
    • Denial: Appeal rights and deadlines provided
  5. Specialty Pharmacy Coordination
    • Patient contacted for delivery scheduling
    • Financial counseling for copay assistance
    • Ongoing refill management

Clinician Corner: Medical Necessity Letter Checklist

Your oncologist's letter should include:

  • Diagnosis: ICD-10 codes and pathology confirmation
  • Prior Treatments: Specific agents tried, duration, and outcomes
  • Clinical Rationale: Why Bavencio is appropriate for this patient
  • Guideline Support: Reference to NCCN or other recognized guidelines
  • Monitoring Plan: How treatment response will be assessed

Timeline Expectations

Standard Review Timeline

  • Initial Review: 5-10 business days from complete submission
  • Expedited Review: 72 hours for urgent cases (life-threatening situations)
  • Peer-to-Peer: Additional 3-5 days if requested
  • Appeal Review: 30 days for internal appeals

Virginia External Review Timeline

  • Request Deadline: 120 days from final internal denial
  • Preliminary Review: 5 business days (insurer eligibility check)
  • Independent Review: 45 days for standard cases
  • Expedited External Review: 72 hours for urgent medical situations

Clinical Criteria and Requirements

FDA-Approved Indications Covered

  1. Metastatic Merkel Cell Carcinoma
    • First-line treatment for advanced disease
    • No prior systemic therapy requirements typically
  2. Urothelial Carcinoma Maintenance
    • After first-line platinum-based chemotherapy
    • Disease must not have progressed
    • Documentation of platinum therapy response required

Step Therapy Considerations

For urothelial carcinoma, Anthem may require:

  • Trial of preferred platinum-based regimens first
  • Documentation of contraindications to preferred agents
  • Evidence of disease stability after initial chemotherapy
Tip: Gather complete chemotherapy records including infusion dates, cycles completed, and response assessments before submitting.

Understanding Costs

Typical Cost Structure

  • Specialty Tier Copay: Variable by plan (often $100-500+ per month)
  • Coinsurance: May apply after deductible
  • Administration Costs: Separate billing for infusion services

Financial Assistance Options

  • EMD Serono Patient Assistance Program: Income-based assistance for uninsured/underinsured
  • Pfizer Oncology Together: Copay assistance and patient support
  • Specialty Pharmacy Support: Financial counselors help navigate options

Contact your specialty pharmacy care team to explore all available assistance programs.

Common Denial Reasons and Solutions

Denial Reason How to Overturn
Off-pathway use Submit NCCN guidelines supporting indication
Insufficient prior therapy Document all previous treatments with dates/outcomes
Missing clinical documentation Provide complete pathology, imaging, treatment notes
Step therapy not met Request exception with contraindication documentation
Site of care restriction Appeal with medical necessity for current setting

Scripts for Common Situations

Patient Phone Script for Status Check: "Hello, I'm calling to check the status of my prior authorization for Bavencio, prescription number [X]. My member ID is [Y]. Can you tell me if any additional information is needed and the expected decision date?"

Clinic Script for Peer-to-Peer Request: "We received a denial for Bavencio for our patient with [diagnosis]. We'd like to request a peer-to-peer review with the medical director. The patient has [specific clinical circumstances] that support medical necessity."

Virginia Appeals Process

Internal Appeals (First Step)

  • Deadline: Typically 180 days from denial notice
  • Submit to: Blue Cross Blue Shield member services
  • Include: Original denial letter, additional clinical evidence, physician appeal letter

Virginia External Review (Independent Review)

When internal appeals fail, Virginia offers robust external review rights:

Eligibility Requirements:

  • Virginia-issued insurance plan (or opted-in self-funded plan)
  • Denial based on medical necessity, experimental treatment, or clinical judgment
  • Internal appeals completed or deemed exhausted

How to File:

  1. Complete Form 216-A External Review Request
  2. Submit within 120 days of final internal denial
  3. Include all supporting documentation and medical records

Submission Options:

  • Fax: (804) 371-9915
  • Email: [email protected]
  • Mail: State Corporation Commission, Bureau of Insurance – External Review, P.O. Box 1157, Richmond, VA 23218

Virginia's Expedited Process: For urgent cases where delay could jeopardize health:

  • Provider completes Form 216-C certification
  • Decision within 72 hours
  • Available even before completing internal appeals for certain cancer treatments

Specialty Pharmacy Requirements

Why Specialty Pharmacy?

Bavencio requires specialized handling, storage, and patient support that standard pharmacies cannot provide.

Key Specialty Pharmacy Partners

  • Biologics, Inc. (McKesson Specialty Health): Primary distributor
  • Accredo (Express Scripts): Common BCBS-preferred specialty pharmacy

What to Expect

  1. Initial Contact: Specialty pharmacy calls within 24-48 hours of approval
  2. Financial Counseling: Review of insurance benefits and assistance programs
  3. Delivery Coordination: Scheduled delivery to clinic or infusion center
  4. Ongoing Support: Refill management and side effect monitoring resources

Frequently Asked Questions

Q: How long does BCBS prior authorization take in Virginia? A: Standard reviews take 5-10 business days. Expedited reviews for urgent cases are completed within 72 hours.

Q: What if Bavencio isn't on my formulary? A: Request a formulary exception with documentation of medical necessity and failure/contraindications to preferred alternatives.

Q: Can I request an expedited appeal? A: Yes, if your physician certifies that delay could seriously jeopardize your health. Virginia allows expedited external review within 72 hours.

Q: What happens if I move from another state? A: Previous treatment history from other states counts toward step therapy requirements. Gather all prior medical records.

Q: Does step therapy apply to Merkel cell carcinoma? A: Generally no, as Bavencio is often first-line treatment. Step therapy more commonly applies to urothelial carcinoma cases.

Q: How often do I need reauthorization? A: Typically every 6 months, though this varies by plan. Your specialty pharmacy will coordinate renewal requests.

Q: What if my doctor isn't in-network? A: Out-of-network providers can still prescribe, but you may need additional approvals and face higher costs.

Q: Can I appeal if I disagree with quantity limits? A: Yes, submit clinical justification for why standard dosing/frequency limits don't meet your medical needs.

When to Escalate

Contact Virginia Regulators When:

  • Multiple appeal denials without adequate review
  • Procedural violations in the appeals process
  • Urgent medical needs not addressed appropriately
  • Plan fails to follow Virginia insurance laws

Virginia State Corporation Commission Bureau of Insurance

Additional Virginia Resources

  • Virginia Poverty Law Center Health Assistance: Legal help for complex appeals
  • Office of the Managed Care Ombudsman: Specialized support for HMO/managed care issues

How Counterforce Health Can Help

Counterforce Health specializes in turning insurance denials into successful appeals by analyzing denial letters, plan policies, and clinical notes to create targeted, evidence-backed appeals. The platform identifies the specific denial basis—whether it's prior authorization criteria, step therapy requirements, or "not medically necessary" determinations—and drafts point-by-point rebuttals aligned to your plan's own rules.

For Bavencio appeals, Counterforce Health pulls the right citations from FDA labeling, peer-reviewed studies, and specialty guidelines, weaving them into appeals with required clinical facts like diagnosis codes, prior treatment failures, and treatment goals. The system produces letters that meet Virginia's procedural requirements while tracking deadlines and required documentation.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Always consult with your healthcare provider and insurance plan for specific coverage decisions. Coverage policies and procedures may change; verify current requirements with your insurer and Virginia regulatory authorities.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.